Record Revenue and Adjusted EBITDA
Revenue of $81.2M in Q1 2026, up 10.5% year-over-year; adjusted EBITDA reached a record $20.1M, up 24.1% year-over-year, with adjusted EBITDA margin improving to 24.8% from 22% a year ago.
Strong Profitability and Operating Income
Operating income of $7.5M, up 71.6% year-over-year; net income of $5.9M, up 36.4% year-over-year; earnings per share of $0.20 versus $0.14 in the prior-year quarter (≈+42.9%).
Healthy Cash Position and Capital Returns
Cash and investments of $66.5M (up from $57M last quarter), no long-term debt, untapped line of credit; free cash flow of $19.7M (up 7.9% YoY); returned capital via $1M dividend and $7.5M of share repurchases in Q1.
Organic and Inorganic Revenue Growth with Successful Acquisitions
Total revenue increase split as organic growth 5.8% and inorganic growth 4.7%; Verisys (Versus)12 and MissionCare Collective contributed $3.4M in Q1 and are integrating well; company expects ~ $13M contribution from those acquisitions for the full year.
Product-Level Momentum — Credentialing, Scheduling, and Learning
CredentialStream revenue grew ~19% YoY; ShiftWizard revenue grew ~29% YoY; Competency Suite revenues increased 17.3% in Q1; legacy-to-modern migrations driving adoption of newer solution set.
Career Networks Engagement and Strategic Potential
Career Networks contributed ~$3.78M in Q1 and produced meaningful engagement: NurseGrid ~683K monthly active users, My Clinical Exchange connected 364K students to clinical placements last year, MyCNAjobs reaches ~70% of the U.S. direct care workforce; >450K hStream IDs created to date.
Strong Backlog and Revenue Visibility
Remaining performance obligations of $687M (vs. $613M a year ago); management expects ~39% of RPO to convert to revenue over the next 12 months and ~67% over 24 months, supporting forward revenue visibility.
Reaffirmed Full-Year Guidance and Q2 Outlook
Company reaffirmed FY2026 guidance: revenue $323M–$330M, net income $20.4M–$22.8M, adjusted EBITDA $73M–$77M; Q2 revenue growth expected to approximate 9.5% with adjusted EBITDA margin ≈23%.